TABLE 2.
Enriched projection | Region | p-value | Corrected p-value |
NAcMed | NAcMed output | 3.31E-09 | 1.06E-07 |
NAcMed | VP output | 4.93E-02 | 5.31E-01 |
NAcMed | PO input | 1.50E-01 | 8.80E-01 |
NAcMed | LHb input | 1.55E-01 | 8.80E-01 |
NAcMed | VP input | 2.25E-01 | 8.99E-01 |
NAcMed | LDT input | 6.07E-01 | 9.74E-01 |
NAcLat | DLS output | 7.43E-07 | 2.23E-05 |
NAcLat | NAcLat output | 2.57E-05 | 6.94E-04 |
NAcLat | NAcLat input | 3.00E-04 | 7.76E-03 |
NAcLat | DMS output | 4.69E-04 | 1.17E-02 |
NAcLat | NAcCore input | 2.47E-03 | 5.54E-02 |
NAcLat | Cortex input | 6.15E-03 | 1.27E-01 |
NAcLat | NAcCore output | 6.09E-02 | 5.85E-01 |
NAcLat | DStr input | 1.57E-01 | 8.80E-01 |
NAcLat | GPe input | 2.69E-01 | 9.19E-01 |
NAcLat | NAcMed input | 2.78E-01 | 9.19E-01 |
NAcLat | Septum input | 3.64E-01 | 9.34E-01 |
mPFC | mPFC output | 8.87E-06 | 2.48E-04 |
mPFC | DR input | 9.29E-03 | 1.62E-01 |
mPFC | Septum output | 1.51E-02 | 2.28E-01 |
mPFC | EP input | 5.19E-01 | 9.74E-01 |
Amygdala | BNST output | 3.35E-08 | 1.04E-06 |
Amygdala | CeA output | 2.93E-06 | 8.50E-05 |
Amygdala | CeA input | 1.23E-03 | 2.91E-02 |
Amygdala | PBN input | 6.24E-03 | 1.27E-01 |
Amygdala | ZI input | 7.06E-03 | 1.32E-01 |
Amygdala | PVH input | 1.14E-02 | 1.86E-01 |
Amygdala | BNST input | 2.15E-02 | 2.93E-01 |
Amygdala | EAM input | 1.97E-01 | 8.89E-01 |
Amygdala | DCN input | 5.69E-01 | 9.74E-01 |
Amygdala | LH input | 7.01E-01 | 9.74E-01 |
Amygdala | MHb input | 8.77E-01 | 9.74E-01 |
| |||
Corrected p-value < 0.05 | |||
Uncorrected p-value < 0.05 |
Significance tests comparing projections for each input and output. For each input and output, the sample mean of the most enriched projection was compared against the remaining projections with a T-test. p-values are corrected for multiple comparisons using a Bonferroni correction.